Leidos Holdings Deep Value Investment Research

Hunting ten-year five-baggers among great growth stocks — pressing the upside question: "Can it get much bigger?"

• QHow high is its market ceiling? Is it expanding an existing pie, or creating an entirely new market?5/10

  A

  Bottom line: Leidos is almost entirely "expanding an existing pie", not creating a new market. The U.S. government digitization, intelligence, defense, health, and infrastructure contracting markets it serves are long-standing, very large, and moderately growing addressable markets. The ceiling is high enough, but it is "high and flat". That is exactly what the Baillie LTGG framework needs to watch: a high ceiling does not equal a steep compounding slope.

  Start with the size of the pie itself. About 87% of Leidos revenue comes from U.S. government contracts, with about 49% from the Department of Defense and the intelligence community, anchoring demand to the U.S. federal budget. The Department of Defense FY2026 budget request is about $961.6 billion, the military intelligence system top line is about $33.6 billion, and long-running priorities such as federal legacy IT modernization, cybersecurity (CMMC), and AI capability buildout add to that. The addressable market (TAM) is in the hundreds of billions to over a trillion dollars, so this is not a market that is "running out of room". The issue is that the pie itself expands only at a mid-single-digit rate each year, constrained by budget processes, procurement cycles, shutdowns, and recompetes. It is not an emerging market that naturally grows exponentially.

  The evidence that Leidos is expanding an existing pie is direct: FY2025 revenue was about $17.2 billion (a record), organic revenue CAGR over the past three years was about 6.6%, and 2026 revenue guidance is only $18.0–$18.4 billion, implying about 4% year-over-year growth. This is the classic pattern of "growing through share gains, renewals, and modest market expansion inside a mature, intensely competitive contracting ecosystem", with competitors including Booz Allen, CACI, SAIC, Parsons, KBR, Lockheed, Northrop, and many others. Leidos ranks first on the Washington Technology 2025 Top 100 government contractors list (about $11.7 billion of contract value), which shows it is already the largest slice of this pie. Further expansion is constrained by the fact that it already takes a large share.

  Is there any element of "creating a new market"? Only at the margins. The growth areas named in the NorthStar 2030 strategy, including space and maritime, energy infrastructure, digital modernization and cyber, mission software, and managed health services, are essentially "adjacent expansion" within existing government customers, not a brand-new category that did not previously exist and whose rules Leidos defines. Even the high-profile $2.7B Army hypersonic weapon ("Dark Eagle") contract reflects Leidos' role as a contractor on the CHGB/TPS programs since 2019/2021. It is a capacity scale-up of existing capabilities, not demand created from scratch.

  The honest Baillie view: the ceiling is high enough that it is not a constraint, but this is not a steep new market capable of supporting "5x in ten years". Leidos' growth function looks more like "GDP+ replacement within an installed base + share competition" than a "new market penetration curve from 1% to 50%". This is one of the underlying reasons the report assigns a "Watch" rating rather than "Buy".

  Jun 10, 2026
• QCan its revenue at least double over the next five years? Is growth mainly driven by volume, price, or new businesses?3/10

  A

  Bottom line: doubling revenue within five years ($17.2 billion → $34.0 billion+) is almost impossible unless it relies on a very large transformational acquisition. On an organic basis, Leidos is most likely to deliver only mid-single-digit compound growth, or about 25%–35% cumulative growth over five years, far short of doubling. Growth is mainly driven by "volume" (contract execution scale + share), with almost no contribution from "price", while "new businesses" are marginal accelerators rather than the main engine. On Baillie's "five-year doubling" hurdle, Leidos clearly falls short.

  First, the numbers disprove the "doubling" case. FY2025 revenue was about $17.2 billion, and 2026 guidance is $18.0–$18.4 billion, about 4% year over year. Doubling in five years requires about a 14.9% CAGR, while Leidos' organic CAGR over the past three years was only about 6.6%, and Q1 2026 revenue was +4% year over year (organic +3%). The gap is more than 2x. Government contracting is a slow-variable industry. Demand is constrained by budgets and procurement cycles, and structurally it does not produce the kind of doubling curve seen in consumer or software businesses.

  Break down the growth sources one by one:

  Volume (main engine). Leidos' growth almost entirely comes from "winning more and larger contracts and converting backlog into revenue". Q1 2026 total backlog was about $48.4 billion (including about $9.6 billion funded), and remaining performance obligations as of April 3 were about $19.0 billion, with 62% expected to be recognized within 12 months and 82% within 24 months. This provides solid short- and medium-term revenue visibility, but the size of the backlog itself limits the upside for near-term volume expansion. TTM book-to-bill was about 1.1 (only 0.8 in Q1), meaning order growth is only slightly faster than revenue and does not support an accelerated doubling path.

  Price (almost no contribution). This is the key weakness. Many Leidos contracts are formed through bidding or negotiation. In FY2025, 43% of revenue came from FFP (fixed-price) contracts, and 44% came from cost-reimbursement/FPIF contracts. Fixed-price contracts cannot automatically pass through higher costs in the short term when inflation raises input costs (both the report and the 10-K state this clearly, and Q1 2026 Homeland operating margin falling from 7.9% to 4.0% was caused by customer requirement changes on fixed-price programs + acquisition expenses). Leidos does not have consumer monopoly brand-like pricing power. Growth contribution from "price" is basically zero.

  New businesses (accelerators, not the main engine). NorthStar 2030's five pillars (space and maritime, energy infrastructure, digital modernization and cyber, mission software, managed health) plus Entrust ($2.34B cash acquisition, identity security) can indeed add incremental growth, and the $2.7B hypersonic contract will also ramp over time. But these are forces that can lift organic growth from ~3% to ~5%, not to 15%. To truly double, Leidos would need another massive acquisition comparable in scale to the historical Dynetics parent acquisition, while current net debt is about $5.9 billion and net debt/EBITDA is about 2.4x–2.5x, so the balance sheet does not support another large leveraged acquisition in the near term.

  The honest Baillie view: the probability of revenue doubling in five years is low. The realistic path is mid-single-digit organic compounding + occasional bolt-on acquisitions, yielding 25%–35% cumulative growth over five years. Growth is volume-led, price is absent, and new businesses are embellishments. That does not match Baillie's profile of a "high-growth stock that can at least double in five years". Leidos is a stable compounding tool, not a high-growth name.

  Jun 10, 2026
• QAfter five years, what will take over as the next growth engine? Does this "second curve" exist today?4/10

  A

  Bottom line: Leidos' "second curve" already exists today and is visible and tangible, but it looks more like "several adjacent branches of the main curve" than a brand-new engine capable of carrying the company independently and shifting the growth gear. In other words, what takes over five years from now is not a disruptive new species, but the fastest-running areas among the current NorthStar 2030 five pillars. This is where Leidos differs from true high-growth stocks: the second curve exists, but its slope is not enough to drive a generational handoff.

  The candidate follow-on curves already present today:

  First, hypersonics and defense systems ramp-up. The $2.7B Army hypersonic weapon contract ("Dark Eagle", integrating TPS + CHGB) was signed in May 2026, moving from prototype work into low-rate production. Early reporting indicates about 1 unit per month initially, rising later to 2 units per month. Leidos has been a contractor on the program since 2019/2021. This is a real curve already in place, expected to contribute revenue over the next few years, and it sits within the broader rise in U.S. defense priorities.

  Second, AI and digital modernization. Federal legacy IT modernization, cybersecurity (CMMC phased implementation in 2025–2028), and "at scale AI integration" are differentiated capabilities Leidos repeatedly emphasizes. Demand here is long-duration and policy-driven, forming the core of the "digital modernization and cyber" and "mission software" pillars within NorthStar 2030.

  Third, identity/cybersecurity brought by Entrust. The $2.34B cash acquisition of Entrust closed at the end of March 2026, pushing Leidos into the adjacent high-value identity security market. If integration succeeds, this is a new curve with potentially better gross margin structure, but for now it is dragging on Homeland segment margins (Q1 operating margin fell to 4.0%), and the integration return remains unproven.

  Fourth, space and maritime, and energy infrastructure. These are the relatively "new" expansion directions inside NorthStar 2030, extending the customer base beyond pure federal work, but they currently represent a small share and are more like medium- to long-term seeds.

  Why is this not a gear-shifting second curve? Three honest limits:

  1. These curves all remain in the same gravity field: U.S. government procurement. They diversify end markets but do not change Leidos' fundamental dependence on federal budgets, budget processes, and bidding mechanisms, so they cannot shift the company from "medium-speed compounding" to "high-speed growth".

  2. The scale is asymmetric. When the main business already has $17.2 billion of revenue, any single new curve that becomes the "next main engine" within five years must grow to several billions of dollars. No current curve combines that scale with that growth rate. Overall guidance remains $18.0–$18.4 billion (about 4% year over year).

  3. It is "portfolio optimization", not "self-disruption". Leidos is also divesting/JV-ing SES/Industrial Automation and Analogic to sharpen strategic focus. This kind of "add one piece, subtract one piece" portfolio adjustment is essentially optimization of the installed base, not incubation of a second species.

  The honest Baillie view: the second curve exists today and is not a PPT concept (hypersonics, AI modernization, and Entrust identity security are all contracted and/or consolidated). But they are adjacent extensions of the main curve, sharing the same government-demand parent body, and neither their scale nor their growth rate is enough to make the company generationally different. Against Baillie's standard of a "second curve visible today that can independently carry the flag in the future", Leidos is "present, but on the weak side".

  Jun 10, 2026
• QWhat is its core competitive advantage? Will this moat widen or narrow over the next three to five years?5/10

  A

  Bottom line: Leidos' core competitive advantage is a combination of "institutional barriers + execution barriers": regulatory qualifications/security clearances, scale, past performance, customer switching costs, and cleared talent. But this moat is "real but not deep, stable but not clearly widening". Over the next three to five years, the most likely judgment is "maintained, perhaps modestly reinforced, but not materially widened". This is the core basis for the report's 3/5 moat-strength score, and from a Baillie perspective it is a "medium moat".

  First, what the moat consists of, ranked by strength:

  • License/regulatory barriers (relatively strong). About 53% of company employees hold U.S. security clearances; cybersecurity qualifications such as CMMC are being phased in during 2025–2028 and will further raise the entry threshold for contractors. This is the hardest part of Leidos' moat, and directionally it is widening (the higher the compliance threshold, the harder it is for new entrants).
  • Scale (clear). About 50,000 global employees, and No. 1 on the Washington Technology 2025 Top 100 government contractors list (about $11.7 billion of contract value). Scale means higher bid density, broader customer coverage, stronger delivery capacity, and efficiency advantages in shared back office and subcontractor coordination.
  • Switching costs (medium-high). For mission-critical projects such as FAA air traffic control, DoD, VA, intelligence systems, and EHR integration, changing vendors involves certifications, system migration, mission continuity, and security risks. It is not a simple price comparison.
  • Corporate culture and operating capability (medium-strong). The share of cleared talent, STEM personnel, long-term customer coverage, and backlog continuity form its real "soft moat".

  Then the three clear weaker areas:

  • Intellectual property (weak). The company itself says its technical services and products generally do not rely on patent protection, and the U.S. government has certain rights to government-funded data/software. That means there is no patent-type barrier.
  • Pricing power (weak/limited). Many contracts are formed through bidding or negotiation, FFP accounts for about 43% of revenue, and cost increases cannot be passed through in the short term. Q1 2026 Homeland operating margin falling from 7.9% to 4.0% was caused by customer requirement changes on fixed-price programs. The moat protects "access", but it does not protect "profit from being eroded by individual projects".
  • Data/network effects (limited/none). It is not an advertising or data platform and has no data flywheel.

  Over the next three to five years, will the moat widen or narrow? My judgment is "narrowly reinforced, but no qualitative change".

  Forces that widen it: higher compliance thresholds such as CMMC + scarce security clearances + AI integration capability + deeper project data and past performance once large programs are won (such as the $2.7B hypersonic contract). All of these make it harder to "copy Leidos".

  Forces that narrow it: government procurement reform (Army acquisition reform is already pushing contract simplification), margin volatility from a high fixed-price contract share, many competitors (Booz Allen, CACI, SAIC, Parsons, KBR, Lockheed, Northrop, etc.), and the spread of AI tools, which could reduce execution barriers in certain standardized delivery tasks.

  Key caveat: the extent to which the moat truly converts into pricing power/excess profit is limited. Leidos' FY2025 operating margin was about 12.3%, and FY2025 adjusted EBITDA margin was about 14.1%. This is an "attractive but not windfall" business. The moat protects "long-term contract access and installed work that rivals cannot easily take away", not "the ability to raise prices at will".

  The honest Baillie view: the moat is real, grounded in institutions and execution, and directionally it should widen modestly (higher compliance thresholds are a tailwind), but it is neither exclusive (the competitor list is long) nor deep enough to support absolute pricing power. Over three to five years, it is most likely "maintained + slightly wider", with no "flywheel-like widening". Leidos can only earn a medium-stable assessment against Baillie's preference for a "moat that will clearly widen in the future".

  Jun 10, 2026
• QIf the core business is disrupted, does it have the DNA for self-reinvention? How does it handle mistakes and bad news?5/10

  A

  Bottom line: Leidos has a "moderate capacity for self-reinvention". It is good at using organizational restructuring, portfolio adjustment, and capability-building acquisitions to follow customer demand as it migrates, but this is "adaptive reinvention", not "disruptive rebirth". In handling mistakes and bad news, the company is relatively candid in disclosure and has mature governance, but it has also paid tuition historically (the SES impairment). Overall, it has a self-adjustment gene, but it is not the kind of resilient species that can be reborn if the core is disrupted. This Baillie question asks about "self-reinvention DNA"; Leidos' answer is "medium, powered by systems rather than founder will".

  Start with the "self-reinvention DNA": the evidence is positive but limited.

  Leidos has shown sustained organizational agility. In FY2025 it still had four segments: National Security & Digital / Health & Civil / Commercial & International / Defense Systems. By Q1 FY2026 it had reorganized into Intelligence & Digital / Health / Homeland / Defense, actively rearranging the organization around customer mission contexts. It is also doing "addition and subtraction": acquiring Kudu Dynamics and Entrust ($2.34B) to enter identity security, while combining SES/Industrial Automation and Analogic into a JV to focus on NorthStar 2030. This shows management is not clinging to legacy businesses and is willing to keep adjusting around "where customer priorities move, we move the organization".

  But this reinvention has clear boundaries: it always migrates within the parent body of U.S. government procurement, and it has not, and probably cannot, change the sector from the root. So it can respond when "customer demand shifts from project category A to project category B", but it may not be able to respond if "the entire government contracting model is disrupted by a new paradigm, such as customers building AI capabilities in-house at scale and bypassing outsourcers". In Baillie's sense of "self-reinvention when the core business is disrupted", Leidos' ammunition is mainly "change the organization, change the portfolio, buy capabilities", not "reinvent the business model".

  Now look at "how it handles mistakes and bad news": this is a window into management integrity, and Leidos is above average.

  Positive: disclosure is relatively full and does not avoid bad news. In 2023, the SES reporting unit recorded a $596 million goodwill impairment. The company recognized it directly, operating profit fell to $621 million that year, and it did not hide the damage. Profit then recovered in 2024–2025 to $1.827 billion and $2.109 billion, showing that it can move past a failed asset. In Q1 2026, Homeland segment margin fell from 7.9% to 4.0%, and the company directly attributed it to customer requirement changes on fixed-price programs + acquisition/JV expenses, without dressing it up. On the August 2022 DOJ antitrust grand jury subpoena, the company continues to disclose in its 10-Q that the investigation is ongoing and that possible fines cannot currently be reasonably estimated. This posture of "candidly disclosing unresolved risks" is a positive. Governance also includes a clawback mechanism, 95% say-on-pay support, and an independent chair.

  Warning: the SES impairment itself is evidence of an "acquisition judgment mistake", reminding us that Leidos can make capital allocation errors. Recent repurchase prices (about $174.94/share in 2026 Q1) were materially above the current about $123/share, showing that there remains a gap between "admitting mistakes" and "avoiding the next mistake". Honest disclosure does not mean decisions are always smart.

  Weaker alignment reduces reinvention drive: as of February 27, 2026, directors and executives together owned only about 0.77% of the company's shares, and CEO Tom Bell beneficially owned about 127,520 shares. Low insider ownership means self-reinvention relies more on an "institutionalized strategic process" than on "founder-like do-or-die will", which may be less decisive in a true existential crisis than an owner-operator company.

  The honest Baillie view: the self-reinvention gene is "institutional, adaptive, and medium-strength". Leidos is good at rearranging its organization and portfolio alongside customers, but it is not built for disruptive remaking. It handles mistakes and bad news candidly, discloses enough, and can recover from impairments, but low insider ownership + historical acquisition mistakes + repurchases at high prices show that it is better at "admitting mistakes" than at "making fewer mistakes". This is a mature, steady, reflective company, but not the kind of resilient species that can rise from the ashes if disrupted.

  Jun 10, 2026
• QDoes management (especially the founder) have a long-term view and deep alignment with the company? Is it willing to sacrifice current profit for five to ten years out?4/10

  A

  Bottom line: Leidos has no founder. It is a large listed contractor led by professional managers, with mature governance but weak owner alignment. Management has a clear long-term strategy (NorthStar 2030) and is willing to make portfolio adjustments for the long term, but the intensity of "sacrificing current profit for five to ten years out like a major shareholder" is only medium. Low insider ownership is the key weakness. Baillie places heavy weight on "founder + long-term view + deep alignment", and this is where Leidos loses the most points.

  First, on "long-term view": Leidos passes.

  The company has a clear multi-year NorthStar 2030 strategy, built around five pillars: space and maritime, energy infrastructure, digital modernization and cyber, mission software, and managed health. It is willing to do "addition and subtraction": acquiring Entrust ($2.34B cash) to enter identity security, combining SES/Analogic into a JV to refocus on the core, and signing the $2.7B multi-year hypersonic contract. These are multi-year layouts, not quarterly games. CEO Tom Bell has continued to emphasize alignment between strategy and customer priorities since taking office, and the direction is clear.

  Then, on "willingness to sacrifice current profit for the long term": the evidence is mixed and leans neutral.

  The willing side: Entrust integration directly dragged on the Homeland segment in Q1 2026, with operating margin dropping from 7.9% to 4.0% (including acquisition integration expenses), yet management continued to push ahead. This is an example of "accepting short-term profit pain for a long-term layout".

  The less willing side: Leidos also maintains fairly active current capital returns (ongoing dividends + large buybacks). Even with net debt up to about $5.9 billion and net debt/EBITDA around 2.4x–2.5x, it still repurchased $200 million in 2026 Q1 (average price about $174.94). This looks more like "maintaining shareholder return discipline + smoothing EPS" than the extreme long-termism of "putting every dollar into the highest-return opportunity ten years out". R&D investment is also low: self-funded R&D expense in 2025 was only $187 million, 1.1% of revenue. That fits the contractor industry norm of "customers fund R&D", but it also shows this is not a company betting its own balance sheet heavily on the future.

  The key weakness: alignment is thin.

  As of February 27, 2026, directors and executives together owned only about 0.77% of company shares. CEO Tom Bell beneficially owned about 127,520 shares, worth only about $15.70 million at the current about $123/share, compared with his 2025 total compensation of about $14.74 million. The degree to which his net worth is tied to the stock is not high. The company does have positive institutional design: the CEO is required to hold 6x salary in stock, incentives are equity-heavy, there is clawback, no single-trigger change-in-control acceleration, 95% say-on-pay support, and an independent chair. But institutionalized "required ownership" differs from a founder voluntarily tying most of personal net worth to the company. The latter is the strong signal of "true alignment" in Baillie's eyes, and Leidos lacks it.

  The honest Baillie view: the long-term view is present (NorthStar 2030 is clear), governance is mature (full disclosure, proper systems), and management is willing to absorb short-term margin pain for strategic positioning (Entrust weighs on margin but is still moving forward). But there is no founder, insider ownership is only about 0.77%, and high-price buybacks show capital allocation is "acceptable but not brilliant". The degree to which "management thinks like major shareholders" is only medium. This is a high-quality company run prudently by professional managers, not a Baillie-style founder-led company with personal wealth staked on ten-year outcomes.

  Jun 10, 2026
• QIf it disappeared tomorrow, how much would customers miss it? Is its growth sustainable and not dependent on harming society or regulation?6/10

  A

  Bottom line: if Leidos disappeared tomorrow, its government customers would "miss it quite a lot". It carries mission-critical projects in air traffic control, defense systems, intelligence analysis, veteran healthcare, homeland security screening, and other areas, and it would be hard to replace seamlessly in the short term. Its indispensability is "high, but substitutability objectively exists". On whether growth harms society or regulatory sustainability, Leidos has almost no ethical liability: it serves government public functions, its growth model is clean, and regulation itself is its moat rather than its opponent. This Baillie question tests both "indispensability + social/regulatory sustainability". Leidos scores medium-high on the former and high on the latter.

  First dimension: indispensability, high but not unique.

  Why customers would miss it (real and strong): many systems operated by Leidos are critical infrastructure where "shutdown means real trouble". It serves FAA air traffic control systems, DoD defense systems, the intelligence community, VA and public health EHR integration, homeland security detection equipment, and more. The report notes that for these mission-critical projects, changing vendors involves certification, system migration, mission continuity, and security risk. That is exactly the source of "medium-high" switching costs. The latest $2.7B Army hypersonic weapon contract ("Dark Eagle") is a national strategic capability, and Leidos has been the CHGB/TPS contractor since 2019/2021, with no seamless short-term substitute. Add about 53% of employees holding security clearances and No. 1 on the Washington Technology Top 100, and it is a leading integrator in the government technology contracting ecosystem. Customers would miss it a great deal.

  But it is not "irreplaceable": the government contracting industry has many competitors, including Booz Allen, CACI, SAIC, Parsons, KBR, Lockheed, Northrop, IBM, Accenture Federal, and others that can take on work in their respective strengths. U.S. government contracts are designed with "for convenience" termination rights and recompete mechanisms precisely to avoid excessive dependence on a single vendor. So "missing Leidos" mainly means "switching would be painful, time-consuming, and costly", not "without Leidos the task cannot be done". That falls short of Baillie's most extreme version of indispensability, where part of the world would break if the company disappeared.

  Second dimension: whether the growth model is sustainable and does not harm society or regulation. Leidos looks very clean here.

  Leidos' growth is built on helping the U.S. government perform public functions such as defense, intelligence, air traffic safety, veteran healthcare, and energy infrastructure. About 87% of revenue comes from U.S. government contracts. It does not grow by harming consumers, exploiting regulatory arbitrage, or creating social externalities. On the contrary, tighter regulation is a tailwind: cybersecurity qualifications such as CMMC are being phased in during 2025–2028, raising entry barriers for contractors and benefiting leading firms like Leidos. Its growth aligns with the long-term legitimate demand for "national security + public service modernization", so social sustainability is strong.

  The one compliance risk to watch: the August 2022 federal grand jury subpoena from the DOJ Antitrust Division involving three government procurements related to the intelligence group in 2021–2022. The investigation remains ongoing, and the company says it cannot reasonably estimate possible fines or liabilities. This is a real unresolved item, but it is a "process compliance dispute", not evidence that the business model itself harms society. It does not change the legitimacy of Leidos' growth model, but it reminds us that compliance is an ongoing cost in government contracting.

  The honest Baillie view: customers would "miss" Leidos quite a lot (mission-critical work, costly switching, leading position), but indispensability is "high rather than unique". There is a long list of competitors, and the government deliberately preserves substitutability. The growth model, however, is highly sustainable and society/regulation-friendly (serving public functions, with tighter regulation becoming a moat). The one item to monitor is the unresolved DOJ antitrust investigation. Overall: medium-high indispensability and high social/regulatory sustainability.

  Jun 10, 2026
• QWhat are the unit economics of this business (gross margin, incremental returns)? Do they improve or deteriorate with scale? Where does the money it earns go?5/10

  A

  Bottom line: Leidos' unit economics are "moderate, steady, but lacking software-style leverage". It is a government services company built on labor + subcontractors + materials + compliance management. Neither gross margin nor incremental returns are high. As scale grows, it gets "gradual improvements in efficiency and coverage", not a "near-zero marginal cost flywheel". The money it earns mainly goes to M&A, buybacks, dividends, and deleveraging. Baillie places heavy weight on "unit economics + incremental returns + scale effects", and Leidos is "solid but ordinary" on this dimension.

  Start with the nature of the unit economics: non-platform, no near-zero marginal cost.

  Leidos is not selling standardized software licenses with 70%+ gross margins like a SaaS company. It earns money from management, technology, execution, and risk control inside contract frameworks. In Q1 FY2026, the four segments together had direct labor of about $1.002 billion and other segment expenses of about $2.843 billion, showing a cost structure that is highly labor + subcontractor intensive. That means its "gross margin" is far below that of platform companies. At the consolidated level, FY2025 operating margin was about 12.3%, FY2025 adjusted EBITDA margin was about 14.1%, and 2026 guidance implies adjusted EBITDA margin around "mid-13". This is an "attractive but not windfall" business. Incremental revenue does not bring software-like high marginal profit.

  Incremental returns are tightly constrained by contract structure.

  The margin ceiling is locked by contract types: in FY2025, 44% of revenue came from cost-reimbursement + FPIF, 43% from FFP, and 13% from T&M/FPLOE. Cost-reimbursement work has low risk but naturally lower margins; FFP has higher profit potential but also high cost-overrun risk. Q1 2026 Homeland took the hit from fixed-price work, with operating margin dropping from 7.9% to 4.0% (customer requirement changes on fixed-price programs + acquisition expenses). So the incremental return from "taking one more project" depends heavily on contract type and execution, with no structural increasing leverage.

  As scale grows, improvement is gradual, not flywheel-like.

  The better side: leading scale (about 50,000 employees, No. 1 on the Washington Tech Top 100) does bring efficiency advantages in shared back office, bid density, talent access, and subcontractor coordination. Margins recovered over the past two years from the 2023 impairment trough of 4.0% to 12.3% in 2025, showing that scaled delivery capability is working.

  But the ceiling is clear: scale cannot break through the constraints of "bidding + government budget + fixed-price risk". You will not see Leidos lift margins to 30% simply because it doubles in size. Its scale effect is "keeping the 12%–14% range stable, with occasional upside", not "margin rising exponentially with scale". This is exactly what separates it from true high-unit-economics growth stocks such as software or strong brands.

  Where the money goes: four destinations, but capital allocation quality is "acceptable rather than brilliant".

  FY2025 free cash flow was about $1.625 billion, and 2026 operating cash flow guidance is about $1.8 billion. The money mainly went to: ① M&A: Entrust $2.34B cash acquisition; ② buybacks: year-end shares outstanding fell from about 140 million in 2021 to about 125.8 million in April 2026, but the 2026 Q1 buyback average price was about $174.94, materially above the current about $123, lowering the capital allocation score; ③ dividends; ④ deleveraging, which should receive more priority going forward (net debt/EBITDA is already about 2.4x–2.5x). R&D spend is light (2025 self-funded R&D was only 1.1% of revenue), consistent with the industry convention that "customers fund R&D".

  The honest Baillie view: unit economics are moderately solid but lack software leverage. The gross margin structure is locked by labor/subcontractors and contract type, with overall margins in the 12%–14% range. Incremental returns are constrained by FFP risk, and scale effects are gradual improvements rather than a flywheel. The money goes to M&A + buybacks + dividends + needed deleveraging, but high-price buybacks show allocation is "acceptable rather than brilliant". This is a business with real cash flow and adequate returns, but not the high-quality compounding machine Baillie prefers, where unit economics improve as scale grows.

  Jun 10, 2026
• QWhat conditions must all hold for it to rise fivefold in ten years? Are those conditions realistic? What expectations are embedded in today's share price?3/10

  A

  Bottom line: for Leidos to rise fivefold over ten years from the current about $123.52/share, it needs about a 17.5% annualized total return. That requires five conditions to hold simultaneously: "sustained mid- to high-single-digit revenue growth + margin expansion + a major valuation multiple uplift + continued buybacks + smooth deleveraging". For a government contractor with about 4% revenue growth, a medium moat, and constrained contract economics, that combination is unlikely. Today's share price at about 11x TTM PE and about 10x forward PE embeds exactly "low expectations": the market is pricing only slow compounding + integration risk + an investigation overhang, with almost no high-growth premium. This Baillie question asks "what conditions are needed for 5x in ten years + what today's price embeds". Leidos' answer is "demanding conditions + expectations already compressed very low".

  First translate "5x" into a mathematical hurdle. At the current price of about $123.52, a fivefold return in ten years means about 17.5% annualized shareholder total return. The Baillie "5x in ten years" yardstick mentioned in the report is far above even its own optimistic scenario upper bound (expected annualized return in the optimistic scenario is only about 12%–14%). In other words, even the report's most optimistic assumptions do not reach the slope required for 5x. That is the first honest red light.

  The five conditions needed for 5x, and their realism one by one:

  1. Sustained mid- to high-single-digit revenue growth. Current 2026 guidance is $18.0–$18.4 billion, about 4% year over year, and organic CAGR over the past three years was about 6.6%. To support 5x, growth needs to stay at mid- to high-single digits or higher for a long time. That requires defense budgets to stay elevated (the Department of Defense FY2026 request of about $961.6 billion is a tailwind) + new contracts such as hypersonics ramping + contribution from acquisitions such as Entrust. Realism: medium, but sustaining it for ten years without slowing is hard.

  2. Structural margin expansion. Current adjusted EBITDA margin is about 14.1% (2026 guidance "mid-13"). But contract structure (FFP at 43%, bid-based pricing, Homeland margin already down to 4.0%) limits room for large improvement. Realism: low to medium-low. Contractor margins are hard to widen persistently.

  3. Major valuation multiple uplift (re-rating). This is the most important and least controllable lever for 5x. Current TTM PE is only about 11.3, and forward PE is about 10x (based on 2026 EPS guidance of $12.10–$12.50). In theory, if the market reclassified it as a growth stock and lifted the multiple from 11x to 18–20x, that would contribute meaningful upside. But this requires a fundamental change in how the market views government contractors, and historically the valuation band for these names is fairly stable. Realism: low and uncontrollable.

  4. Continued buybacks shrinking the share count. Shares outstanding have fallen from about 140 million in 2021 to about 125.8 million in April 2026, which is the right direction. But the recent average repurchase price of about $174.94 (above the current price) means share-count reduction efficiency is discounted, and deleveraging needs to come first. Realism: medium. It can continue, but not aggressively.

  5. Smooth deleveraging. Current net debt is about $5.9 billion, with net debt/EBITDA about 2.4x–2.5x. Entrust integration + deleveraging will absorb cash flow over the next few years, crowding out buybacks/reinvestment. Realism: medium, but it is a constraint.

  Multiply the five conditions together: each is individually "possible", but the joint probability of all being realized at a high level over ten years is low. The more realistic picture is the one in the report: conservative 6%–8%, base 9%–11%, optimistic 12%–14% annualized, implying about 1.8x–3.7x over ten years rather than 5x.

  What does today's share price imply? The answer is "low expectations, with many bad-news items already reflected".

  • The current about $123.52 share price is close to the 52-week low of $121.20, about 40% below the 52-week high of $205.77; market cap is about $15.5 billion.
  • TTM PE is about 11.3, and forward PE is about 10x, low among mature government contractors (the report lists peers at BAH about 11.8x, CACI about 21.2x, SAIC about 13.4x, KBR about 11.2x).
  • This means the market gives Leidos almost no high-growth premium. Instead it is pricing integration risk (Entrust dragging margins) + higher leverage + DOJ investigation uncertainty + fixed-price project volatility. In other words, a large part of pessimism is already embedded. That creates a narrow opportunity from the "odds" angle, but it is not the logic of "5x in ten years".

  The honest Baillie view: 5x in ten years requires revenue growth, margins, valuation multiple, buybacks, and deleveraging to all deliver at a high level simultaneously. The joint probability is low, and even the report's own optimistic scenario cannot reach that slope. Today's price at about 10–11x PE and near a 52-week low embeds low expectations of "slow compounding + multiple risks already reflected". That gives it some appeal on "odds/margin of safety", but it clearly fails Baillie's "5x upside imagination over ten years" dimension. This stock is "expectations are low and it may not be expensive", not "expectations are reasonable and 5x is plausible".

  Jun 10, 2026
• QWhy has the market not realized all this yet? Is it because investors do not understand it, look down on it, or cannot look far enough? What will be the "narrative inflection point"?3/10

  A

  Bottom line: using Baillie's "do not understand / look down on / cannot look far enough" framework, the best description for Leidos is "look down on it + partly cannot look far enough". The market does not misunderstand it (coverage is sufficient and the model is clear). It gives Leidos a discount label for "low growth, heavy dependence on government budgets, and M&A + investigation risk", and is unwilling to pay a growth premium. But we must be honest: much of this discount is reasonable, not a market mistake. The essence of this Baillie question is "where is the market wrong, and what becomes the narrative inflection point?" For Leidos, the more accurate answer is "the market pricing is broadly correct, and any potential repair comes from risk clearing rather than growth re-rating".

  Rule out the three possible forms of "the market has not realized it" one by one:

  "Does not understand": mostly not true. Leidos is a large listed company with ample analyst coverage (11 analysts have a Buy consensus and a price target of about $189.55), a clear business model (government digitization/intelligence/defense/engineering contracting), and detailed financial disclosures. The market can fully understand this business. It is not an overlooked obscure small-cap. So the path that "the perception gap comes from not understanding" basically does not work.

  "Looks down on it": this is the main reason, and partly justified. The market assigns the government contracting industry a structurally low valuation band. The current price is about $123.52, TTM PE is about 11.3, and forward PE is about 10x, close to the 52-week low of $121.20 and about 40% below the high of $205.77. The reasons the market "looks down on it" are specific: ① slow growth (2026 guidance implies about 4% year-over-year growth); ② heavy dependence on the federal budget and procurement cycles, with government shutdown/recompete risk always overhead; ③ weak pricing power, FFP at 43%, and Homeland margin already down to 4.0%; ④ Entrust raises leverage (net debt/EBITDA about 2.4x–2.5x) and tangible net assets are negative; ⑤ the DOJ antitrust investigation remains unresolved. These are not irrational biases but real reasons for a discount. The report itself sets valuation at the "lower end of a reasonable range" and says the margin of safety is not obvious; it does not claim the market has severely mispriced the stock.

  "Cannot look far enough": somewhat true, but not a strong perception gap. The market may be underestimating several medium- to long-term tailwinds: the $2.7B hypersonic contract ramp, higher CMMC compliance thresholds benefiting leaders, elevated defense budgets (FY2026 Department of Defense request about $961.6 billion), and NorthStar 2030 adjacent expansion. But these are "moderate tailwinds", not "seriously overlooked exponential opportunities". Fully reflecting them would only repair valuation from "cheap" to "reasonable", not support a growth-stock re-rating.

  The key honest point: this is a "discounted stock" thesis, not a "hidden growth stock" thesis. The report's conclusion is "Watch, margin of safety not obvious, ideal entry at $95–$110". That itself shows the author does not think the market is making a major mistake. Instead, the current price is "near the lower end of fair value but not cheap enough". In other words, Leidos is not a case of "the market cannot see a great growth stock that has been wrongly sold off", but a case of "a stable compounder that is reasonably priced and perhaps slightly cheap". The Baillie-style "huge upside the market has not yet realized" is basically absent here.

  What could become the "narrative inflection point"? Three possibilities, mostly "risk-clearing" rather than "growth-breakout":

  1. DOJ investigation resolved (the most realistic discount-repair trigger). If the investigation closes without major penalties, the compliance discount weighing on valuation would disappear and the multiple could repair modestly. This would be driven by "bad news realized/removed", not growth.

  2. Entrust integration delivers + leverage comes down. If over the next two to three years Entrust contributes returns above the cost of capital, net debt/EBITDA falls visibly, and Homeland margins return to normal, the market will regain confidence in management's capital allocation discipline and the valuation discount will narrow.

  3. Defense/AI modernization orders exceed expectations. If hypersonic production + AI integration + large modernization contracts keep book-to-bill above 1 (current TTM about 1.1, Q1 alone only 0.8) and shift growth into the mid- to high-single digits, the market may grant some growth premium. But this requires sustained fundamental upside, and the probability is medium.

  The honest Baillie view: the market does not misunderstand Leidos; it "looks down on it", applying a discount for low growth + government budget dependence + M&A/investigation risk, and that discount is broadly reasonable (the report also only rates it "Watch" and says the margin of safety is not obvious). It is a prudently priced, slightly cheap stable name, not a mispriced growth stock. The narrative inflection point is more likely to come from "bad-news removal" risk clearing, such as DOJ resolution, Entrust integration delivery, and deleveraging, than from a "growth-breakout" re-rating. This does not fit Baillie's pattern of seeking "huge upside the market has not yet realized".

  Jun 10, 2026